drugset / Trial / NCT01281540

An Efficacy and Safety Study of Cisapride in Patients With Chronic Gastroparesis After Failure of Other Treatment Options

NCT01281540 ↗

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to assess the effectiveness of cisapride in patients with a primary diagnosis of chronic gastroparesis (a stomach disorder) of unknown cause.

Timeline

Start
2003-05
Primary completion
—
Completion
2003-11

Outcome

Outcome not reported

Stopped: “Sponsor request”

Drugs

EvaluationDrugModalityDoseRoute
Subject Cisapride Small molecule 10 mg Oral

Indications